| RS2548555289 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2548555301 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS2548555307 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548555532 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2548555667 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548555793 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2548555829 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548555876 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548555893 |
BRCA2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548556239 |
BRCA2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2548556248 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548557919 |
ATP2A2
|
Health Risk |
Pathogenic |
— |
| RS2548561116 |
ATP2A2
|
Health Risk |
Likely pathogenic |
ATP2A2-related disorder, ATP2A2-related disorder |
| RS2548561345 |
ATP2A2
|
Health Risk |
Pathogenic |
— |
| RS2548561448 |
UBE3B
|
Health Risk |
Likely pathogenic |
Oculocerebrofacial syndrome, Kaufman type |
| RS2548561932 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary breast ovarian cancer syndrome |
| RS2548561959 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548561967 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548562009 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548562101 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS2548562157 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548562206 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2548562252 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548562287 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548562319 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548562327 |
BRCA2
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548562350 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2548562367 |
BRCA2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, BRCA2-related disorder |
| RS2548562386 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548562468 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548562505 |
BRCA2
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2548562544 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548563282 |
ATP2A2
|
Health Risk |
Pathogenic |
Keratosis follicularis, Keratosis follicularis |
| RS2548563297 |
ATP2A2
|
Health Risk |
Likely pathogenic |
ATP2A2-related disorder, ATP2A2-related disorder |
| RS2548563592 |
BRCA2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548563596 |
BRCA2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548563661 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2548563732 |
BRCA2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2548563744 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548563785 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548563794 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2548564094 |
ATP2A2
|
Health Risk |
Pathogenic |
— |
| RS2548564104 |
ATP2A2
|
Health Risk |
Likely pathogenic |
— |
| RS2548564652 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548564685 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548564737 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2548564773 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548564784 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548564800 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548564872 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2548565181 |
ATP2A2
|
Health Risk |
Likely pathogenic |
— |
| RS2548565742 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS2548565787 |
UBE3B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, Blepharophimosis - intellectual disability syndrome |
| RS2548566690 |
ATP2A2
|
Health Risk |
Pathogenic |
— |
| RS2548575169 |
UBE3B
|
Health Risk |
Pathogenic |
— |
| RS2548575756 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome type 6, Joubert syndrome 17 |
| RS2548577530 |
UBE3B
|
Health Risk |
Pathogenic |
— |
| RS2548581513 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2548581688 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548581742 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548581758 |
RUNX2
|
Health Risk |
Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS2548581809 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548581818 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548581855 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548582134 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS2548582226 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548582230 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2548582244 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548584165 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2548585932 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2548588606 |
NALCN
|
Health Risk |
Pathogenic |
— |
| RS2548588658 |
UBE3B
|
Health Risk |
Pathogenic |
Oculocerebrofacial syndrome, Kaufman type |
| RS2548588794 |
NALCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital contractures of the limbs and face, hypotonia |
| RS2548589063 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS2548589112 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2548589176 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2548589234 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548589263 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548589267 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548589271 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548589285 |
RUNX2
|
Health Risk |
Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS2548589416 |
NALCN
|
Health Risk |
Likely pathogenic |
Hypotonia, infantile |
| RS2548591444 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548591542 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548593491 |
RUNX2
|
Health Risk |
Likely pathogenic |
— |
| RS2548593499 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548593538 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548593549 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548593562 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548593578 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548593597 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS2548597368 |
WNK1
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS2548602004 |
CPLANE1
|
Health Risk |
Likely pathogenic |
— |
| RS2548602308 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548603971 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548604009 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548604090 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548604098 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS2548604300 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS2548604750 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |